Literature DB >> 1653277

Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment.

M Hill1, R McCallum.   

Abstract

The molecular mechanism involved in altered regulation of the rate-limiting enzyme in hepatic gluconeogenesis, phosphoenolpyruvate carboxykinase (PEPCK), during endotoxemia is not completely understood. We examined, therefore, the effect of a nonlethal dose of Escherichia coli endotoxin on PEPCK gene expression in fasted rats. 5 h after endotoxin treatment, the PEPCK transcription rate and the amount of mRNA(PEPCK) were significantly decreased at a time when the insulin/glucagon (I/G) molar ratio and plasma corticosterone levels were significantly increased. Similar results were observed in a time course study, in which altered cAMP induction of PEPCK gene expression paralleled changes in the I/G molar ratio. In diabetic rats treated with endotoxin, PEPCK gene expression was decreased in the absence, however, of an increased I/G molar ratio. This finding indicates that other factors, such as inflammatory mediators or cytokines, alter PEPCK gene transcription during endotoxemia. IL-6, a putative mediator of endotoxin action in the liver, had no effect on PEPCK gene expression in fasted rats, but did decrease cAMP induction of PEPCK gene expression. These results indicate that, during endotoxemia, regulation of PEPCK gene expression is influenced by inflammatory mediators in addition to the classical endocrine hormones. IL-6, however, does not appear to be involved directly in the altered regulation of the PEPCK gene during endotoxemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653277      PMCID: PMC295466          DOI: 10.1172/JCI115381

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.

Authors:  D M Jablons; J J Mulé; J K McIntosh; P B Sehgal; L T May; C M Huang; S A Rosenberg; M T Lotze
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

2.  Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man.

Authors:  Y Fong; L L Moldawer; M Marano; H Wei; S B Tatter; R H Clarick; U Santhanam; D Sherris; L T May; P B Sehgal
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

3.  IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo.

Authors:  S Marinkovic; G P Jahreis; G G Wong; H Baumann
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

4.  Failure of glucagon to induce hepatic phosphoenolpyruvate carboxykinase in endotoxic shock.

Authors:  R D Stith; R E McCallum
Journal:  Circ Shock       Date:  1988-11

Review 5.  The molecular biology of insulin action on protein synthesis.

Authors:  D K Granner
Journal:  Kidney Int Suppl       Date:  1987-12       Impact factor: 10.545

6.  3' noncoding region of phosphoenolpyruvate carboxykinase mRNA contains a glucocorticoid-responsive mRNA-stabilizing element.

Authors:  D D Petersen; S R Koch; D K Granner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 7.  Antiglucocorticoid effects of endotoxin.

Authors:  L J Berry; W B Huff
Journal:  Circ Shock       Date:  1984

8.  Cyclic AMP stabilizes the mRNA for phosphoenolpyruvate carboxykinase (GTP) against degradation.

Authors:  Y Hod; R W Hanson
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

9.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Authors:  J Van Snick; S Cayphas; A Vink; C Uyttenhove; P G Coulie; M R Rubira; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression.

Authors:  T Taga; Y Kawanishi; R R Hardy; T Hirano; T Kishimoto
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

2.  The control of hepatic glycogen metabolism in an in vitro model of sepsis.

Authors:  Jennifer Wallington; Jian Ning; Michael Alan Titheradge
Journal:  Mol Cell Biochem       Date:  2007-10-13       Impact factor: 3.396

3.  Trace metal, acute phase and metabolic response to endotoxin in metallothionein-null mice.

Authors:  A M Rofe; J C Philcox; P Coyle
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

4.  Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue.

Authors:  Stéphanie Leroyer; Camille Vatier; Sarah Kadiri; Joëlle Quette; Charles Chapron; Jacqueline Capeau; Bénédicte Antoine
Journal:  J Lipid Res       Date:  2010-11-10       Impact factor: 5.922

5.  Impairment by interleukin 1 beta and tumour necrosis factor alpha of the glucagon-induced increase in phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis in cultured rat hepatocytes.

Authors:  B Christ; A Nath
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

6.  Impact of interleukin-6 on the glucose metabolic capacity in rat liver.

Authors:  Bianca Lienenlüke; Bruno Christ
Journal:  Histochem Cell Biol       Date:  2007-09-06       Impact factor: 4.304

7.  Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice.

Authors:  M R Hill; R E McCallum
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  The effect of treatment of the rat with bacterial endotoxin on gluconeogenesis and pyruvate metabolism in subsequently isolated hepatocytes.

Authors:  C G Jones; M A Titheradge
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

Review 9.  Clinical potential of insulin therapy in critically ill patients.

Authors:  Dieter Mesotten; Greet Van den Berghe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Lipopolysaccharide regulation of lipoprotein lipase expression in murine macrophages.

Authors:  M R Hill; K Kelly; X Wu; F Wanker; H Bass; C Morgan; C Wang; J M Gimble
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.